Stocktoria

Lineage Cell Therapeutics, Inc. LCTX

NYSE · stock · Biological Products, (No Diagnostic Substances) · website · IPO 1992-03-05

Lineage Cell Therapeutics, Inc. statistics & valuation

Market cap$336.6M
P / S23.1×
P / B7.6×
Net margin-436.5%
Return on equity-142.6%
FCF margin-133.6%
Return on capital-36.2%

Market cap as of 2026-06-30. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Net margin (%)
566.80% -577.70% -922.00% -333.10% -1130.80% -991.00% -178.70% -240.20% -195.90% -436.50% 2016201720182019202020212022202320242025
Gross margin (%)
94.00% 95.10% 93.90% 88.30% 78.90% 67.20% 95.00% 92.50% 2016201720182019202020212022202320242025
Operating margin (%)
-995.60% -1125.00% -837.90% -1106.00% -1448.40% -1133.60% -153.20% -276.50% -226.10% -251.60% 2016201720182019202020212022202320242025
Return on equity (%)
25.70% -12.20% -49.90% -10.40% -21.50% -46.60% -35.80% -33.90% -23.70% -142.60% 2016201720182019202020212022202320242025
Shares outstanding
102.8M 126.9M 127.1M 149.8M 153.1M 169.5M 170.1M 175.0M 220.4M 243.1M 2016201720182019202020212022202320242025
Net debt ($)
2016201720182019202020212022202320242025
Share buybacks ($)
2016201720182019202020212022202320242025
Return on assets (%)
23.50% -11.50% -45.20% -9.30% -19.10% -24.60% -21.20% -21.30% -16.40% -56.40% 2016201720182019202020212022202320242025
Free cash flow margin (%)
-752.60% -920.90% -630.30% -921.40% -1085.30% -550.60% 4.40% -326.90% -249.00% -133.60% 2016201720182019202020212022202320242025
Debt / equity (×)
2016201720182019202020212022202320242025
EPS ($)
$0.34 -$0.17 -$0.15 -$0.12 -$0.09 -$0.28 2016201720182019202020212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Gross margin——92.5%95.0%67.2%78.9%88.3%93.9%95.1%94.0%
Operating margin-251.6%-226.1%-276.5%-153.2%-1133.6%-1448.4%-1106.0%-837.9%-1125.0%-995.6%
Net margin-436.5%-195.9%-240.2%-178.7%-991.0%-1130.8%-333.1%-922.0%-577.7%566.8%
FCF margin-133.6%-249.0%-326.9%4.4%-550.6%-1085.3%-921.4%-630.3%-920.9%-752.6%
Return on assets-56.4%-16.4%-21.3%-21.2%-24.6%-19.1%-9.3%-45.2%-11.5%23.5%
Return on equity-142.6%-23.7%-33.9%-35.8%-46.6%-21.5%-10.4%-49.9%-12.2%25.7%
Current ratio5.203.652.143.162.375.668.865.346.202.90

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.